+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurological Devices Market Report Suite - United States - 2020-2026 - Medsuite

  • ID: 4876617
  • Report
  • November 2019
  • Region: United States
  • 432 Pages
  • iData Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • FHC
  • LivaNova
  • Nevro
  • Scientia Vascular
  • MORE
Throughout this medical market research, the publisher analyzed 44 neurology companies in the United States and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the US neurological device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a neurological procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered
  • Procedure Volumes for Neurological Devices – MedPro
  • Cerebrospinal Fluid Management Market – MedCore
  • Detachable Coils Market – MedCore
  • Liquid Embolics Market – MedCore
  • Neurovascular Catheters Market – MedCore
  • Neurovascular Guidewires Market – MedCore
  • Neurovascular Stents Market – MedCore
  • Balloon Occlusion Market – MedCore
  • Aneurysm Clips Market – MedCore
  • Neurovascular Thrombus Management Market – MedCore
  • Neuromodulation Devices Market – MedCore
  • Intrathecal Pumps Market – MedCore
  • Stereotactic Surgery Devices Market – MedCore
  • Neuroendoscopy Market – MedCore
  • Ultrasonic Aspirators Market – MedCore
Neurological Device Market Insights

The neuromodulation devices comprise the largest segment for neurological devices, divided between several competitors in the spinal cord stimulation and deep brain stimulation space. Most other segments, including vagus nerve stimulation, gastric electric stimulation, dorsal root ganglion stimulation and responsive neurostimulation remain monopolized market segments at the time of publication.

With aging demographics and improved early detection, procedure volumes for treating aneurysms are on the rise. Recent clinical trials have demonstrated the greater efficacy of flow-diverting and intrasaccular stents, compared to established techniques.

Overall, the U.S. neuromodulation, neurovascular and neurosurgical device market was valued at $4.8 billion in 2019. This is expected to increase over the forecast period at a CAGR of 6.9% to reach $7.6 billion.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • FHC
  • LivaNova
  • Nevro
  • Scientia Vascular
  • MORE
TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

1. EXECUTIVE SUMMARY

U.S. NEUROMODULATION, NEUROVASCULAR AND NEUROSURGICAL DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW

2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics and Neurosurgery
2.2.3 Tumor and Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication for Neuromodulation
2.2.9 Traumatic Brain Injury

3. U.S. NEUROMODULATION, NEUROVASCULAR AND NEUROSURGICAL DEVICE MARKET OVERVIEW

3.1 INTRODUCTION
3.1.1 Cerebrospinal Fluid Management
3.1.2 Interventional Neuroradiology
3.1.3 Neuromodulation
3.1.4 Neurosurgery
3.1.5 Neurovascular Thrombectomy
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.1.1 Cerebrospinal Fluid Management
3.4.1.2 Interventional Neuroradiology
3.4.1.3 Neuromodulation
3.4.1.4 Neurosurgery
3.4.1.5 Neurovascular Thrombectomy
3.4.2 Market Limiters
3.4.2.1 Cerebrospinal Fluid Management
3.4.2.2 Interventional Neuroradiology
3.4.2.3 Neuromodulation
3.4.2.4 Neurosurgery
3.4.2.5 Neurovascular Thrombectomy
3.5 COMPETITIVE MARKET SHARE ANALYSIS
3.6 MERGERS AND ACQUISITIONS

4. NEUROLOGICAL PROCEDURE NUMBERS

4.1 PROCEDURE ANALYSIS AND FORECAST
4.1.1 Cerebrospinal Fluid Shunting Procedures
4.1.2 Interventional Treatment of Saccular Aneurysm Procedures
4.1.3 Liquid Embolization of AVM Procedures
4.1.4 Neurovascular Thrombus Management Procedures
4.1.5 Neuromodulation Procedures
4.1.5.1 Spinal Cord Stimulation Procedures
4.1.5.2 Deep Brain Stimulation Procedures
4.1.6 Intrathecal Pump Procedures
4.1.7 Stereotactic Surgery Procedures
4.1.8 Ultrasonic Aspiration Procedures

5. CEREBROSPINAL FLUID MANAGEMENT MARKET

5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Cerebrospinal Fluid Shunt Market
5.3.1.1 Adjustable Pressure Cerebrospinal Fluid Shunt Market
5.3.1.2 Fixed Pressure Cerebrospinal Fluid Shunt Market
5.3.2 Total Cerebrospinal Fluid External Drainage System Market
5.3.2.1 Ventricular Drainage System Market
5.3.2.2 Lumbar Drainage System Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS

6. DETACHABLE COIL MARKET

6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Detachable Coil Market
6.3.2 Bare Platinum Detachable Coil Market
6.3.3 Coated Detachable Coil Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE MARKET SHARE ANALYSIS

7. LIQUID EMBOLIC MARKET

7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE MARKET SHARE ANALYSIS

8. NEUROVASCULAR CATHETER MARKET

8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Over-the-Wire Microcatheter Market
8.3.2 Flow-Directed Microcatheter Market
8.3.3 Neurovascular Guiding Catheter Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS

9. NEUROVASCULAR GUIDEWIRE MARKET

9.1 INTRODUCTION
9.2 MARKET ANALYSIS AND FORECAST
9.3 DRIVERS AND LIMITERS
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 COMPETITIVE MARKET SHARE ANALYSIS

10. NEUROVASCULAR STENT MARKET

10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Traditional Neurovascular Stent Market
10.3.2 Flow Diversion Stent Market
10.3.3 Intrasaccular Stent Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS

11. BALLOON OCCLUSION DEVICE MARKET

11.1 INTRODUCTION
11.2 MARKET ANALYSIS AND FORECAST
11.3 DRIVERS AND LIMITERS
11.3.1 Market Drivers
11.3.2 Market Limiters
11.4 COMPETITIVE MARKET SHARE ANALYSIS

12. ANEURYSM CLIP MARKET

12.1 INTRODUCTION
12.2 MARKET ANALYSIS AND FORECAST
12.2.1 Total Aneurysm Clip Market
12.2.2 Aneurysm Clip Market by Indication
12.2.2.1 Permanent Aneurysm Clip Market
12.2.2.2 Temporary Aneurysm Clip Market
12.2.3 Aneurysm Clip Market by Material
12.2.3.1 Titanium Aneurysm Clip Market
12.2.3.2 Cobalt Chromium Aneurysm Clip Market
12.3 DRIVERS AND LIMITERS
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 COMPETITIVE MARKET SHARE ANALYSIS

13. NEUROVASCULAR THROMBUS MANAGEMENT MARKET

13.1 INTRODUCTION
13.1.1 Market Overview
13.2 MARKET ANALYSIS AND FORECAST
13.2.1 Stent Retriever Market
13.2.2 Aspiration Catheter Market
13.3 DRIVERS AND LIMITERS
13.3.1 Market Drivers
13.3.2 Market Limiters
13.4 COMPETITIVE MARKET SHARE ANALYSIS

14. NEUROMODULATION DEVICE MARKET

14.1 INTRODUCTION
14.1.1 Spinal Cord Stimulation
14.1.2 Deep Brain Stimulation
14.1.3 Sacral Nerve Stimulation
14.1.4 Vagus Nerve Stimulation
14.1.5 Gastric Electric Stimulation
14.1.6 Dorsal Root Ganglion Stimulation
14.1.7 Responsive Neurostimulation
14.2 MARKET OVERVIEW
14.3 MARKET ANALYSIS AND FORECAST
14.3.1 Spinal Cord Stimulation Market
14.3.1.1 Spinal Cord Stimulation Generator Market by Battery Type
14.3.1.1.1 Rechargeable Spinal Cord Stimulation Generator Market
14.3.1.1.2 Non-Rechargeable Spinal Cord Stimulation Generator Market
14.3.1.3 Spinal Cord Stimulation Market by Channel Type
14.3.1.3.1 Dual-Channel Spinal Cord Stimulation Market
14.3.1.3.2 Tri-Channel Spinal Cord Stimulation Market
14.3.1.3.3 Quad-Channel Spinal Cord Stimulation Market
14.3.1.4 Spinal Cord Stimulation Lead Market
14.3.1.5 Spinal Cord Stimulation Implants by Application
14.3.2 Deep Brain Stimulation Market
14.3.3 Sacral Nerve Stimulation Market
14.3.4 Vagus Nerve Stimulation Market
14.3.5 Gastric Electric Stimulation Market
14.3.6 Dorsal Root Ganglion Stimulation Market
14.3.7 Responsive Neurostimulation Device Market
14.4 DRIVERS AND LIMITERS
14.4.1 Spinal Cord Stimulation Market
14.4.1.1 Market Drivers
14.4.1.2 Market Limiters
14.4.2 Deep Brain Stimulation Market
14.4.2.1 Market Drivers
14.4.2.2 Market Limiters
14.4.3 Sacral Nerve Stimulation Market
14.4.3.1 Market Drivers
14.4.3.2 Market Limiters
14.4.4 Vagus Nerve Stimulation Market
14.4.4.1 Market Drivers
14.4.4.2 Market Limiters
14.4.5 Gastric Electric Stimulation Market
14.4.5.1 Market Drivers
14.4.5.2 Market Limiters
14.4.6 Dorsal Root Ganglion Stimulation Market
14.4.6.1 Market Drivers
14.4.6.2 Market Limiters
14.4.7 Responsive Neurostimulation Device Market
14.4.7.1 Market Drivers
14.4.7.2 Market Limiters
14.5 COMPETITIVE MARKET SHARE ANALYSIS

15. INTRATHECAL PUMP MARKET

15.1 INTRODUCTION
15.2 MARKET ANALYSIS AND FORECAST
15.3 DRIVERS AND LIMITERS
15.3.1 Market Drivers
15.3.2 Market Limiters
15.4 COMPETITIVE MARKET SHARE ANALYSIS

16. STEREOTACTIC MARKET

16.1 INTRODUCTION
16.2 MARKET OVERVIEW
16.3 MARKET ANALYSIS AND FORECAST
16.3.1 Frame-Based Stereotactic Market
16.3.2 Frameless Stereotactic Market
16.4 INSTALLED BASE ANALYSIS
16.4.1 Frame-Based Stereotactic Market
16.4.2 Frameless Stereotactic Market
16.5 DRIVERS AND LIMITERS
16.5.1 Market Drivers
16.5.2 Market Limiters
16.6 COMPETITIVE MARKET SHARE ANALYSIS

17. NEUROENDOSCOPY MARKET

17.1 INTRODUCTION
17.2 MARKET OVERVIEW
17.3 MARKET ANALYSIS AND FORECAST
17.3.1 Rigid Endoscope Market
17.3.2 Flexible Endoscope Market
17.3.3 Videoscope Market
17.3.4 Neuroendoscopic Hand Instrument Market
17.3.5 Neuroendoscopy Disposables Market
17.4 DRIVERS AND LIMITERS
17.4.1 Market Drivers
17.4.2 Market Limiters
17.5 COMPETITIVE MARKET SHARE ANALYSIS

18. ULTRASONIC ASPIRATOR MARKET

18.1 INTRODUCTION
18.2 MARKET OVERVIEW
18.3 MARKET ANALYSIS AND FORECAST
18.3.1 Capital Equipment Market
18.3.1.1 Installed Base
18.3.2 Disposable Probe Tip Market
18.3.3 Disposable Tubing Market
18.4 DRIVERS AND LIMITERS
18.4.1 Market Drivers
18.4.2 Market Limiters
18.5 COMPETITIVE MARKET SHARE ANALYSIS

19. APPENDIX: INTRACEREBRAL HEMORRHAGE TREATMENT

19.1 INTRODUCTION
19.2 MARKET DRIVERS

20. ABBREVIATIONS
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • Accuracy
  • Adeor
  • Aesculap
  • Asahi Intecc
  • Axonics
  • Balt
  • Boston Scientific
  • Brainlab
  • Cerenovus
  • Clarus
  • Dewimed
  • Elekta
  • Embolx
  • FHC
  • Flowonix
  • InoMed
  • Integra LifeSciences
  • IntraPace
  • IRRAS
  • Karl Storz
  • LivaNova
  • Medtronic
  • MicroVention
  • Misonix
  • Mizuho America
  • MRC
  • NeuroPace
  • Nevro
  • NICO
  • Nuvectra
  • Penumbra
  • Peter Lazic
  • SAI Infusion Technologies
  • Saluda
  • Scientia Vascular
  • Soring
  • Sophysa
  • Spartan Micro
  • Spiegelberg
  • Stimwave
  • Stryker
  • Vascular Solutions
  • Visionsense
Note: Product cover images may vary from those shown
Adroll
adroll